Beta Bionics (NASDAQ:BBNX) versus Inspire Medical Systems (NYSE:INSP) Head to Head Contrast

Beta Bionics (NASDAQ:BBNX) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

Institutional and Insider Ownership

94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Beta Bionics and Inspire Medical Systems”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$53.03 million	12.14	N/A	N/A	N/A
Inspire Medical Systems	$802.80 million	6.38	$53.51 million	$1.73	99.77

Inspire Medical Systems has higher revenue and earnings than Beta Bionics.

Analyst Ratings

This is a breakdown of current recommendations for Beta Bionics and Inspire Medical Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	0	3	5	1	2.78
Inspire Medical Systems	0	3	8	0	2.73

Beta Bionics presently has a consensus target price of $24.83, suggesting a potential upside of 65.34%. Inspire Medical Systems has a consensus target price of $228.82, suggesting a potential upside of 32.57%. Given Beta Bionics’ stronger consensus rating and higher possible upside, analysts clearly believe Beta Bionics is more favorable than Inspire Medical Systems.

Profitability

This table compares Beta Bionics and Inspire Medical Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Beta Bionics	N/A	N/A	N/A
Inspire Medical Systems	6.67%	8.19%	7.09%

Summary

Inspire Medical Systems beats Beta Bionics on 7 of the 11 factors compared between the two stocks.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.